Fingerprint
Dive into the research topics of 'Phase II trial of the combination of denileukin diftitox and rituximab for relapsed/refractory B-cell non-Hodgkin lymphoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II trial of the combination of denileukin diftitox and rituximab for relapsed/refractory B-cell non-Hodgkin lymphoma
Nam H. Dang, Luis Fayad, Peter McLaughlin, Jorge E. Romaguara, Fredrick Hagemeister, Andre Goy, Sattva Neelapu, Felipe Samaniego, Pamela L. Walker, Michael Wang, Maria A. Rodriguez, Ann T. Tong, Barbara Pro
Research output: Contribution to journal › Article › peer-review
32
Scopus
citations